The next important step is treatment - and again the data show that when statin therapy (our initial and ideal therapy currently in patients with FH) is appropriately prescribed, the result is significantly improved CHD-free survival rates in patients with FH.  These are data (Figure) that were published in the BMJ in 2008 showing that when statin-treated patients are compared to a cohort of non-statin treated patients with FH, the cumulative event-free survival rates are significantly greater in those treated with statins than those who are not treated with statins.  These are observational data, not the results of a placebo-controlled, blinded study (doing such a study in FH patients would be considered unethical), but they clearly show that patients who have been treated with statins seem to do better.